Ustekinumab is a Safe and Effective Biological Agent for Crohn's Disease in a Liver Transplant Patient

被引：11
|
作者：
Peverelle, Matthew [1 ]
Asadi, Khashayar [2 ]
De Cruz, Peter [1 ,3 ]
机构：
[1] Austin Hlth, Dept Gastroenterol, Melbourne, Vic, Australia
[2] Austin Hlth, Dept Anat Pathol, Melbourne, Vic, Australia
[3] Univ Melbourne, Austin Acad Ctr, Dept Med, Melbourne, Vic, Australia
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷 / 10期
关键词：
Ustekinumab; Crohn's disease; liver transplantation; MAINTENANCE THERAPY; INDUCTION;
D O I：
10.1093/ecco-jcc/jjaa062
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1498 / 1499
页数：2
相关论文
共 50 条
  • [1] Ustekinumab is effective and safe in the treatment of Crohn's disease refractory to anti-TNFα in an orthotopic liver transplant patient
    Martinez-Montiel, M.
    Piedracoba-Cadahia, Pilar
    Gomez-Gomez, Carlos
    Gonzalo, J.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (09) : 816 - 817
  • [2] Ustekinumab is safe and effective in pediatric patients with Crohn's disease
    Mitchel, Elana B.
    Dolinger, Michael T.
    Constant, Brad
    Wang, Zi
    Guisado, Daniela
    Gao, Michael
    Fusillo, Steven
    Baldassano, Robert N.
    Kelsen, Judith
    Dubinsky, Marla
    Huang, Jing
    Albenberg, Lindsey
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2025, : 653 - 663
  • [3] Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn’s Disease Patients
    Gerum Gashaw Gebeyehu
    Joseph Fiske
    Eleanor Liu
    Jimmy K. Limdi
    Giacomo Broglio
    Christian Selinger
    Violeta Razsanskaite
    Philip J. Smith
    Paul K. Flanagan
    Sreedhar Subramanian
    Digestive Diseases and Sciences, 2023, 68 : 1983 - 1994
  • [4] Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn's Disease Patients
    Gebeyehu, Gerum Gashaw
    Fiske, Joseph
    Liu, Eleanor
    Limdi, Jimmy K.
    Broglio, Giacomo
    Selinger, Christian
    Razsanskaite, Violeta
    Smith, Philip J.
    Flanagan, Paul K.
    Subramanian, Sreedhar
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (05) : 1983 - 1994
  • [5] Is Ustekinumab Effective in Refractory Crohn's Disease of the Pouch and Chronic Pouchitis? A Systematic Review
    Rocchi, Chiara
    Soliman, Youssef Y.
    Massidda, Marco
    di Prampero, Salvatore F. Vadala
    Bulajic, Milutin
    Sorrentino, Dario
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (06) : 1948 - 1955
  • [6] Ustekinumab as the First Biological Agent for Crohn's Disease in a 10-Year-Old Girl
    Fujita, Yuji
    Sugaya, Takeshi
    Tanaka, Takanao
    Tominaga, Keiichi
    Yoshihara, Shigemi
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 255 (01) : 57 - 60
  • [7] Ustekinumab is effective in biological refractory Crohn's disease patients-regardless of approval study selection criteria
    Saman, Sadik
    Goetz, Martin
    Wendler, Judith
    Malek, Nisar P.
    Wehkamp, Tan
    Klag, Thomas
    INTESTINAL RESEARCH, 2019, 17 (03) : 340 - 348
  • [8] Ustekinumab to treat Crohn's disease
    Gisbert, Javier P.
    Chaparro, Maria
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2017, 40 (10): : 688 - 698
  • [9] Ustekinumab for the treatment of Crohn's disease
    Khanna, Reena
    Feagan, Brian G.
    IMMUNOTHERAPY, 2013, 5 (08) : 803 - 815
  • [10] Ustekinumab for the treatment of Crohn's disease
    Hansen, Tawnya
    Targownik, Laura E.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (09) : 989 - 994
12345